Tianxiang Tu

494 citations
14 papers · 386 indexed · h-index 11
Topics
CRISPR and Genetic Engineering (5 papers)Virus-based gene therapy research (2 papers)Epigenetics and DNA Methylation (2 papers)

In The Last Decade

Tianxiang Tu

14 papers receiving 383 citations

Peers

Tianxiang Tu
Comparison fields: 5 of 64
  • Molecular Biology 298
  • Oncology 62
  • Immunology and Allergy 41
  • Pulmonary and Respiratory Medicine 37
  • Cancer Research 36
Replace Sybille Böhm with:
Sybille Böhm Germany
Tiing Jen Loh South Korea
Déborah Meyran Australia
Elliot H. Akama‐Garren United States
Paula A. Clark United Kingdom
Caleb A. Dawson Australia
Stéphane Bécart United States
Jean-Loup Salzmann France
Srimathi Srinivasan United States
R Basu United States
Tianxiang Tu relative to Sybille Böhm Germany Sybille Böhm's profile →
Citations per field
00.5×4.6×
Sybille Böhm · 1×
Citations per year

Countries citing papers authored by Tianxiang Tu

Since Specialization
Citations

This map shows the geographic impact of Tianxiang Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxiang Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxiang Tu more than expected).

Fields of papers citing papers by Tianxiang Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxiang Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxiang Tu. The network helps show where Tianxiang Tu may publish in the future.

Co-authorship network of co-authors of Tianxiang Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxiang Tu. A scholar is included among the top collaborators of Tianxiang Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxiang Tu. Tianxiang Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 4
2 33
3 20
4 11
5 1
6 10
7 37
8 24
9 24
10 21
11 18
12 13
13 27
14 143

About Tianxiang Tu

Tianxiang Tu is a scholar working on Immunology and Allergy, Molecular Biology and Neurology, having authored 14 papers that have together received 386 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), Virus-based gene therapy research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Business and International Management (15 citations), Immunology and Allergy (41 citations) and Molecular Biology (298 citations). Tianxiang Tu has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Dennis E. Hallahan, Ling Geng, Kyle C. Cuneo, Allie Fu, Peter Atadja, Christopher D. Willey, Arnoud Sonnenberg, Olga M. Viquez, Eugenia M. Yazlovitskaya and Ambra Pozzi. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026